*|MC:SUBJECT|*

Making Connections

GlycoMark Increases Participation in Trade Shows and Events

As part of our mission to raise awareness of the utility of the GlycoMark test in managing patients with diabetes, we will be participating in several conferences and trade shows during 2017. Events where we will be exhibiting include:

American Association of Clinical Endocrinologists in Austin, TX—May 3-7
American Diabetes Association in San Diego, CA—June 9-13
American Association for Clinical Chemistry in San Diego, CA—August 1-3
American Association of Diabetes Educators in Indianapolis, IN—August 4-6

We will also be attending the Executive War College in New Orleans, LA in early May. If you are attending any of these events, be sure to come by and see us. We look forward to sharing GlycoMark success stories with you.

Diabetes Patient Describes
GlycoMark's Impact on Treatment

With the help of a Continuous Glucose Monitor, Daniel “Danny” Phelan was able to achieve an A1C consistently in the 6s. Despite “good control” of his A1C, Danny was still experiencing glucose peaks at different intervals throughout the day. Click here to learn about how Danny and his physician, Dr. Michael Shanik used the the GlycoMark test to better manage his diabetes.

Hirotaka "Hiro" Ishibashi Named COO of GlycoMark

Hiro previously served as Director of International Business Development at GlycoMark before being promoted to COO. Responsibilities include business development, clinical research and FDA regulation and compliance. He will also represent GlycoMark in international conferences on diabetes and on diagnostic/biomarkers

Ishibashi said he is excited about his new role and the vision for GlycoMark. “There is a surge of momentum for the GlycoMark test as more healthcare professions, hospitals, and universities—both in the U.S. and internationally—recognize utility of GlycoMark to indicate hyperglycemic episodes and glycemic variability within one to two weeks.”
Click here for more.